Navigation Links
Trevena, Inc. Announces $24 Million Series A Financing
Date:3/5/2008

Drug Discovery Company to Focus on G-Protein Coupled Receptors

BERWYN, Penn., March 5 /PRNewswire/ -- Trevena, Inc., a drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs), today announced the closing of a $24 million Series A financing. Alta Partners and Healthcare Ventures led the round as part of an investor syndicate that included New Enterprise Associates and Polaris Venture Partners. The company will use the funds to progress its drug discovery portfolio.

"We are very pleased to have attracted an outstanding group of investors, who share our vision and strategy on building a premier drug discovery organization," said Maxine Gowen, Ph.D., President and Chief Executive Officer. "Pharmaceutical products that target GPCRs represent over 40% of marketed drugs today and these targets provide an attractive starting point for new pharmaceutical agents. Trevena's mission will be to utilize a state of the art approach to discover and develop novel GPCR-targeted medicines for patients."

Dr. Gowen was most recently the Senior Vice President of GlaxoSmithKline's Center of Excellence for External Drug Discovery, where she was responsible for delivering compounds with therapeutic proof of concept through partnerships with biotechnology companies. "We are thrilled to have Maxine's leadership and believe Trevena is uniquely positioned to develop new GPCR-based drugs, across multiple therapeutic areas, which could be safe and more effective than current pharmaceuticals," commented Farah Champsi, Managing Partner at Alta Partners.

Trevena has recruited Michael Lark, Ph.D. as Head of Research and Mark Strobeck, Ph.D. as Chief Business Officer. Michael was previously Vice President of Biology Discovery, at Centocor. Mark was formerly Vice President of Business Development for Drug Discovery at GlaxoSmithKline.

Trevena's drug discovery platform, licensed from Duke University M
'/>"/>

SOURCE Trevena, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...eumonia, bronchitis and other acute respiratory in...ord cold temperatures there, the United Nations he...f people and putting in place a system to protect ... “Early recognition and prompt treatment are essen...
...inhibit joint damage when used in the early phase ... of evidence.// High-quality evidence supports c...e first two years after diagnosis. “Such treatment...atients,” say review authors led by John Kirwan of...
...cer face a significantly high risk of getting canc... than 10 percent of these men ultimately developed... breast, stomach and skin. Hence the researchers r...ing is necessary for spotting any possible second ...
...TEMPE, a topical anesthetic spray has the potentia...ith premature ejaculation and might be useful// as...udy is published in the February issue of the urol...chers from the UK and Netherlands studied 54 men w...
Other Medicine News:Health News:UN Sends Medicine to Afghanistan 2Health News:Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis 2Health News:Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis 3Health News:Breast Cancer in Men Lead to Second Primary Cancers 2Health News:TEMPE Spray Delays Ejaculation 2
(Date:8/19/2008)...be used to identify molecular,signature of motor n...ire-USNewswire/ -- ALS Therapy,Development Institu...n ALS,biomarker effort using blood samples collect...ships. These ongoing projects are part of the,Inst...expression of genes,and proteins, at the onset of,...
(Date:8/19/2008)...tCall/ -- Vical Incorporated,(Nasdaq: VICL ) toda...linska,Institute, a leading European medical unive...sease Control (SMI), a governmental expert agency,...e Biojector(R) 2000,needle-free injection system (... a multivalent preventive DNA vaccine against HIV....
(Date:8/18/2008)...The next time you consider popping a,pill when you...ing sheep,instead. A senior psychiatrist at the Sc... found evidence that taking sleeping pills regular...F. Kripke, M.D.,s article, based on a compilation ...s just been published in the Journal,of Sleep Rese...
(Date:8/18/2008)...ased life expectancy for people with,Down syndrome...In the world of Down,syndrome, ,Mr. C, is a rarity...r the past 16 years, at seventy, ,Mr. C, has well ...with Down syndrome, currently in the,late fifties,...,Mr. C, does,not exhibit clinical symptoms of Alzh...
Breaking Medicine Technology:ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Prescription Sleeping Pill Use Tied to Cancer 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3American College of Rheumatology presents recommendations for rheumatoid arthritis therapy 20979 1American College of Rheumatology presents recommendations for rheumatoid arthritis therapy 20979 2American College of Rheumatology presents recommendations for rheumatoid arthritis therapy 20979 3The Hanover Extends Schools Program Making the Grade in GA KS MD and VA 20974 1The Hanover Extends Schools Program Making the Grade in GA KS MD and VA 20974 2The Hanover Extends Schools Program Making the Grade in GA KS MD and VA 20974 3Angiotech announces completion of Bio Seal 28TM 29 clinical trial enrolment 5778 1Angiotech announces completion of Bio Seal 28TM 29 clinical trial enrolment 5778 2Angiotech announces completion of Bio Seal 28TM 29 clinical trial enrolment 5778 3Angiotech announces completion of Bio Seal 28TM 29 clinical trial enrolment 5778 4Sherwood Oregon Sailor 78 Goes on Final Voyage 20968 1Sherwood Oregon Sailor 78 Goes on Final Voyage 20968 2
...-hoc analysis shows nearly nine out of ten patient...t the end of 12 months, WASHINGTON, D.C., May 22, ...II, open-label 12-14 month extension study (303),p...y (BSG) meeting,in Glasgow, Scotland in March 2007...erated in mild to moderate UC,patients. Today, sec...
...ia Maintained Long-term Response at Stable Doses, ...se Week (DDW), ATLANTA, May 22, 2007 /PRNewswire/ ...Digestive Disease Week 2007 (DDW),demonstrated lon...atients treated with Cimzia (certolizumab pegol), .... , The study, called PRECiSE 3 (P3), is a long-te...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: